Lyka Labs gets product permission from CDSCO for Tofacitinib Ointment

10 Oct 2023 Evaluate

Lyka Labs has received the product permission from the Central Drugs Standard Control Organization of India (CDSCO) to Manufacture and Market Tofacitinib Ointment 2% w/w. The company has received this permission after successfully completing the Clinical Trial on 125 patients across 8 Clinical Trial Centers within India. 

Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.

Lyka Labs Share Price

78.32 -2.72 (-3.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×